Advancis Pharmaceutical is now MiddleBrook™ Pharmaceuticals, Inc.

In 2000, MiddleBrook Pharmaceuticals, Inc. made a novel discovery. Bacteria exposed to antibiotics in front-loaded, sequential bursts, or pulses, are killed more efficiently than those exposed to standard antibiotic treatment regimens.

Today, we are working to develop and commercialize pulsatile drug products, applying our patented finding to create a new outlook on anti-infective therapy.
+ Learn more.

May 13, 2008
MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
+ more info

Mar 14, 2008
MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
+ more info

Mar 04, 2008
MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
+ more info